REDWOOD CITY, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that results from its completed Phase 2 study evaluating burixafor, a small molecule CXCR4 antagonist, will be featured in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 6-9, 2025, in Orlando, Florida. The presentation will highlight additional ...

Gevo expands its carbon business with the groundbreaking delivery, adding a new stream of repeatable revenue now including carbon removal credits (CORCs) in addition to ethanol, protein, vegetable oil, and tax credit salesENGLEWOOD, Colo., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) announced the production and delivery of certified carbon dioxide removal credits, known as CORCs under the high-integrity Puro.earth standard, to Biorecro North America, LLC, marking a major milestone in the com ...

ANDOVER, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that Ram Mayampurath, Executive Vice President and Chief Financial Officer will be presenting at Baird Global Industrial Conference on Tuesday, November 11, 2025 at 3:55 p.m. EST. A live webcast of the session will be available in the Investor Relations section of the company's website at https://investor.mksinst.com/events-and-presentations and a r ...

NewGen will issue 500 million shares at US$10 to acquire the mining assets, substantially boosting shareholders’ equity and transforming the merged entity into a multi-billion-dollar conglomerateBANGKOK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health sol ...

GEORGE TOWN, Cayman Islands, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, has been awarded a contract valued at $11.7 million to construct a wastewater recycling plant with 200,000 gallons-per-day capacity and 600,000 gallons of treated water storage for a San Francisco Bay Area golf club. The contract was secured by the company’s California-based subsidiary, PERC Wat ...

The new ROG external GPU delivers Thunderbolt™ 5, up to NVIDIA® GeForce RTX™ 5090 Laptop GPU, and improved cooling for peak portable performance, now in Canada KEY POINTS Performance Meets Versatility: XG Mobile features up to NVIDIA GeForce RTX 5090 Laptop GPU to power up your setup at a maximum 150W TGP.Thunderbolt™ 5 support: Future ready, while maintaining backward compatibility with Thunderbolt™ 4 and USB4 systems.Cooler and quieter: Redesigned vapor chamber with thicker channels and repositioned fan i ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that data from its ongoing Phase 2 study of SLS009 for the treatment of relapsed or refractory acute myeloid leukemia (r/r AML) will be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, being held Dec ...

公司近期动态 - Disc Medicine将于2025年12月6日至9日在佛罗里达州奥兰多举行的美国血液学会（ASH）年会上公布两项海报展示，包括其治疗骨髓纤维化（MF）贫血的研究药物DISC-0974的RALLY-MF二期临床试验的初步数据 [1] - 公司管理层计划在ASH会议期间的2025年12月7日东部时间上午7:30举行电话会议，回顾所公布数据的亮点及后续开发计划 [2] 核心产品管线进展 - 本次ASH年会的展示重点将是DISC-0974在骨髓纤维化贫血患者中的RALLY-MF二期试验的初步数据，该试验涵盖了更广泛的患者群体，包括作为单药疗法以及与JAK抑制剂（如鲁索替尼和莫莫替尼）联合用药的结果 [2] - 公司还将展示另一项研究药物DISC-3405在其二期临床试验中的研究设计，该试验针对真性红细胞增多症（PV）患者，预计将在2026年公布该试验以及DISC-3405在镰状细胞病中的一期b试验的初步结果 [2] 学术会议展示详情 - DISC-0974的海报展示编号为2042，标题为“RALLY MF：一项在骨髓纤维化和贫血患者中评估抗血红素沉着蛋白抗体DISC-0974的二期研究”，将于2025年12月6日东部时间下午5:30至7:30进行，主讲人为Naseema Gangat [4] - DISC-3405的海报展示编号为2053，标题为“一项在真性红细胞增多症参与者中评估DISC-3405的安全性、耐受性、药代动力学、药效学和疗效的二期开放标签研究”，将于同一时间（2025年12月6日东部时间下午5:30至7:30）进行，主讲人为Marcus Carden [5] - 目前已公布的摘要包含先前已公布的数据，新的数据和分析将保留在会议现场公布 [3] 公司业务定位 - Disc Medicine是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对严重血液疾病患者的新型疗法 [6] - 公司正在构建一系列创新的、可能成为“首创”疗法的产品管线，旨在通过靶向红细胞生物学的关键生物学通路（特别是血红素生物合成和铁稳态）来应对广泛的血液疾病 [6]

Sports.com Content Surpasses 45 Million Views A Media Snippet accompanying this announcement is available by clicking on this link. ABU DHABI, United Arab Emirates, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SEGG Media Corporation (Nasdaq: SEGG, LTRYW) (“SEGG Media” or “the Company”), today celebrates a landmark achievement as Racing Women driver Jorden Dolischka became the first woman in history to stand on the Gulf Radical Cup podium at the Formula One Yas Marina Circuit. The weekend marked a breakthrough moment f ...

LAS VEGAS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Innovative Payment Solutions, Inc. (Trading Symbol ‘IPSI’ on OTCID), a provider of digital payment and fintech solutions, today announced the launch of its next-generation Crypto Payment Platform, designed to provide IPSI’s clients including those in online gaming, iGaming, and sportsbook sectors with seamless, compliant, and secure cryptocurrency payment capabilities. This new platform enables operators to accept and process digital assets such as Bitcoin, Ether ...